Overview

Single Dose Study of [14C]-IDV184001AN ([14C]-IDV184001) in Healthy Adult Male Participants

Status:
Completed
Trial end date:
2023-07-21
Target enrollment:
Participant gender:
Summary
The purpose of this open label study is to characterise the absorption, metabolism, excretion, and mass balance of [14C]-IDV184001AN ([14C]-IDV184001) in healthy adult male participants.
Phase:
Phase 1
Details
Lead Sponsor:
Indivior Inc.